Condition 1: Long bone fracture. Condition 2: Investigating the analgesic effect of ketamine. Condition 3: Investigating the analgesic effect of magnesium sulfate + ketamine.
Conditions
Interventions
Intervention 1: Control group: ketamine alone with a dose of 0.3 mg/kg until the sample volume is 20 cc of normal saline, diluted and received as a bolus after registering the vas scoring at zero minu
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: All patients with long bone fractures aged 18 to 65 years and weighing between 60 to 80 kg and with a vas scoring pain level of more than 4 out of 10 have referred to the Golestan hospital emergency room, and there was no pain relief intervention before that, including the prescription of any medication. have not had
Exclusion criteria
Exclusion criteria: Unstable hemodynamics, alcohol consumption, neuromuscular diseases, pregnant and lactating women, high blood pressure (systolic more than 145 mmHg and diastolic more than 100 mmHg), history of benzodiazepine and ketamine use, medical diseases (such as heart failure, liver, kidney, stomach ulcer, cardiac arrhythmia).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Numerical scale of pain intensity. Timepoint: Upon arrival (0) and 5, 15 and 30 minutes. Method of measurement: visual analog scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHassan Motamed
Ahvaz University of Medical Sciences
Outcome results
None listed